2017
DOI: 10.1016/j.clnu.2017.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Reply-Letter to the Editor-The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…Indeed, it has been shown that patients with visceral obesity may develop atherosclerosis, and are particularly prone to CVD [9]. Lipid accumulation product (LAP) index is a biomarker of the central fat accumulation which has recently been developed and been advocated as an accurate indicator of the risk of insulin resistance (IR), MetS, type 2 diabetes, and CVD [10][11][12]. LAP is associated with abnormal glucose homeostasis and IR, as well as increased alanine aminotransferase, in healthy people [13].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, it has been shown that patients with visceral obesity may develop atherosclerosis, and are particularly prone to CVD [9]. Lipid accumulation product (LAP) index is a biomarker of the central fat accumulation which has recently been developed and been advocated as an accurate indicator of the risk of insulin resistance (IR), MetS, type 2 diabetes, and CVD [10][11][12]. LAP is associated with abnormal glucose homeostasis and IR, as well as increased alanine aminotransferase, in healthy people [13].…”
Section: Introductionmentioning
confidence: 99%
“…The lipid accumulation product (LAP) is a powerful parameter based on WC and serum triglycerides (TG) for predicting diabetes in adults by Kahn et al [17][18]. It is an emerging indicator that indirectly expresses central fat accumulation and has been developed to be independently associated with impaired fasting glucose, type 2 diabetes, coronary heart disease and metabolic syndrome [19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…The lipid accumulation product (LAP) is a powerful parameter based on WC and serum triglycerides (TG) for predicting diabetes in adults by Kahn et al [ 19 , 20 ]. It is an emerging indicator that indirectly expresses central fat accumulation and has been developed to be independently associated with impaired fasting glucose, type 2 diabetes, coronary heart disease and metabolic syndrome [ 21 23 ]. Several population-based studies have emphasized the association between LAP and metabolic diseases in different countries [ 24 26 ], but there are few studies to investigate the association between LAP and diabetes in China.…”
Section: Introductionmentioning
confidence: 99%